Philippines - English - FDA (Food And Drug Administration)

scheeling, inc. - cefuroxime (as axetil) - powder for suspension - 250mg/5ml

Philippines - English - FDA (Food And Drug Administration)

hexagon pharmaceuticals; distributor: scheeling pharma care link, inc. - cefuroxime (as axetil) - film-coated tablet - 500mg

Philippines - English - FDA (Food And Drug Administration)

hexagon pharmaceuticals; distributor: scheeling pharma care link, inc. - cefuroxime (as sodium) - powder for injection - 750 mg

Philippines - English - FDA (Food And Drug Administration)

rainbow life sciences pvt ltd.; importer: ambica international corporation; distributor: scheeling, inc. - cefuroxime (as sodium) - powder for injection (im/iv) - 750 mg

Philippines - English - FDA (Food And Drug Administration)

ambica international corporation; distributor: scheeling pharma care link, inc. - cefuroxime (as axetil) - film-coated tablet - 500 mg

Philippines - English - FDA (Food And Drug Administration)

ambica international trading corp; distributor: scheeling, inc. - cefuroxime (as axetil) - powder for oral suspension - 250 mg/5 ml

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

nature`s grace (m) sdn. bhd. - radix codonopsis pilosulae; poria cocos powder; isatidis indigotica; herba epimedii sagittatum; bupleurim falcatum; semen cuscuta chinensis; cordyceps sinensis; herba artemisiae scopariae -

Singapore - English - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - melatonin - tablet, extended release - 2 mg - melatonin 2 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

rad data australia pty ltd - melatonin -

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - melatonin 2mg;  ;   - modified release tablet - 2 mg - active: melatonin 2mg     excipient: ammonio methacrylate copolymer calcium hydrogen phosphate dihydrate colloidal silicon dioxide lactose monohydrate magnesium stearate purified talc - monotherapy for the short term treatment (up to 13 weeks) of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.